CLOV vs CNC: stock comparison and AI forecast
Clover Health Investments, Corp. /De (CLOV) and Centene Corp (CNC) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CLOV Clover Health Investments, Corp. /De
- Price
- $4.82 +70.9% · 6M
- Market Cap
- $2.56B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
CNC Centene Corp
- Price
- $69.74 +26.8% · 6M
- Market Cap
- $34.53B
- P/E Ratio
- 23.2x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- CNC is 13.5 times larger than CLOV by market capitalization ($34.53B against $2.56B).
- Over the last six months CLOV returned +70.9% and CNC +26.8%.
- CNC carries 2.57 times debt per unit of equity, against 0.93 times for CLOV.
- Both companies share the SEC industry classification Hospital & Medical Service Plans.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CLOV | CNC |
|---|---|---|
| Market Cap | $2.56B | $34.53B |
| P/E Ratio | – | 23.17x |
| P/B Ratio | 6.55x | 1.55x |
| EPS | $-0.09 | $3.01 |
| Book Value/Share | $0.74 | $44.86 |
| Revenue/Share | $5.16 | $411.85 |
| FCF/Share | $0.25 | $7.96 |
Profitability & Margins
| Metric | CLOV | CNC |
|---|---|---|
| ROE | – | 6.6% |
| ROA | – | 1.8% |
| ROIC | 3.0% | 2.5% |
| Gross Margin | – | 98.6% |
| Operating Margin | 0.5% | 0.5% |
| Net Margin | – | 0.7% |
| EBT Margin | 0.0% | 0.9% |
| Tax Rate | – | 23.9% |
Financial Health
| Metric | CLOV | CNC |
|---|---|---|
| Current Ratio | 1.55x | 1.16x |
| D/E Ratio | 0.93x | 2.57x |
| Financial Leverage | 1.93x | 3.57x |
| Working Capital | $189M | $6.39B |
Cash Flow
| Metric | CLOV | CNC |
|---|---|---|
| Operating Cash Flow | $135M | $4.72B |
| Free Cash Flow | $132M | $3.94B |
| Capital Spending | -$3M | -$781M |
| OCF Growth YoY | – | 16.2% |
| FCF Growth YoY | – | 17.5% |
| FCF/Sales | 4.8% | 1.9% |
| CapEx/Sales | 0.1% | 0.4% |
Operational Efficiency
| Metric | CLOV | CNC |
|---|---|---|
| Asset Turnover | 3.63x | 2.57x |
| Fixed Assets Turnover | 353.4x | 96.7x |
Income Statement
| Metric | CLOV | CNC |
|---|---|---|
| Total Revenue | $2.74B | $203.90B |
| Operating Income | $12M | $1.01B |
| Net Income | – | $1.46B |
| SG&A Expense | – | $13.11B |
| Cost of Goods Sold | – | $2.79B |
Dividend & Shareholder Information
| Metric | CLOV | CNC |
|---|---|---|
| Shares Outstanding | 531M | 495M |
CLOV vs CNC: stock comparison and AI forecast
Which is bigger, CLOV or CNC?
CNC is 13.5 times larger than CLOV by market capitalization ($34.53B against $2.56B).
Which stock performed better over the last six months, CLOV or CNC?
Over the last six months CLOV returned +70.9% and CNC +26.8%.
Which one does Intratio's AI model rank higher, CLOV or CNC?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.